Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Feasibility and Usability of MyndMove Therapy for FES Facilitated Treatment of Subacute and Chronic Severe Hemiparesis of the Upper Limb Following Stroke

NCT02266836 is registered in ClinicalTrials.gov with MyndTec Inc. as lead sponsor.

NCT NCT02266836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02266836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Feasibility and Usability of MyndMove Therapy for FES Facilitated Treatment of Subacute and Chronic Severe Hemiparesis of the Upper Limb Following Stroke
Lead sponsor
MyndTec Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
October 31, 2015
Enrollment
50 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hemiparesis of the upper limb following stroke